55.04 -1.24 (-2.21%)
CEPH
Stock Details
Last Trade:55.04 Change:-1.24 (-2.21%) Prev Close:56.28 Open: 56.20 Days Range:55.02 – 56.39 52 Week Range: 54.63 - 81.35 Volume:1465524 P/E: 17.75EPS:3.10
View AllRecent Alerts 07/03/09
Recent Alert on 06/25/09 at 5:35pm
Latest Piqqem.com Market Movers (USO, PG, NYT, EBAY)
Latest Piqqem.com Market Movers (USO, PG, NYT, EBAY)
Here is the latest Piqqem Sentiment Market Movers List for the week of 6/25. The Market Movers measurement combines number of active votes on a security at Piqqem.com and percentage change in sentiment ratings on an equity over the previous seven... Read More
Recent Alert on 06/19/09 at 8:40am
Cephalon (CEPH) Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Cephalon (CEPH) Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Recent Alert on 06/19/09 at 8:40am
Cephalon (CEPH) Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Cephalon (CEPH) Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Recent Alert on 06/10/09 at 8:30am
SunTrust Initiates Coverage on Several Drug Manufacturers & Suppliers
SunTrust Initiates Coverage on Several Drug Manufacturers & Suppliers
Recent Alert on 06/01/09 at 9:11am
Cephalon (CEPH) Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Related To Apnea
Cephalon (CEPH) Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Related To Apnea
View AllRecent Press Releases
Press Release on 06/30/09 at 8:00am
Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 07/01/09 at 4:48am
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG